Your browser doesn't support javascript.
loading
Psychiatric and neuropsychiatric issues in persons with COVID-19 infection: A case-control online study from India-Neorealist study.
Vaishnav, Mrugesh; Grover, Sandeep; Vaishnav, Parth; Sharma, Kamal; Avasthi, Ajit.
Afiliación
  • Vaishnav M; Director, Samvedana Happiness Hospital, Ahmedabad, Gujarat, India.
  • Grover S; Department of Psychiatry, Post Graduate Institute of Medical Education and Research, Chandigarh, India.
  • Vaishnav P; Associate Consultant, Samvedana Happiness Hospital, Ahmedabad, Gujarat, India.
  • Sharma K; Department of Cardiology, U.N.Mehta ICRC, B.J.Medical College, Ahmedabad, Gujarat, India.
  • Avasthi A; Senior Consultant Psychiatrist, Fortis Hospital, Mohali, Punjab, India.
Indian J Psychiatry ; 64(5): 473-483, 2022.
Article en En | MEDLINE | ID: mdl-36458084
ABSTRACT

Background:

Many studies across the globe have evaluated the adverse mental health consequences of COVID-19 in patients who suffered from COVID-19 infection. However, a comparative study of persons who suffered from COVID-19 infection and those who witnessed the COVID-19 infection in their close relatives is lacking. Aims and

Objectives:

This study aims to compare the psychiatric morbidity in persons who suffered from COVID-19 infections, and those who witnessed the illness in one of their close relatives.

Methods:

In this cross-sectional online survey, 2,964 adult participants completed the Patient Health Questionnaire-9 (PHQ-9), Generalized Anxiety Disorder-7 (GAD-7) Scale, Fear of COVID-19 Scale (FCS-19), Brief Resilient Coping Scale (BRCS), The Brief Resilience Scale (BRS) and a self-designed questionnaire to evaluate other neuropsychiatric complications.

Results:

Compared to the close relatives who had witnessed COVID-19 infection, participants who developed COVID-19 infection had a significantly higher prevalence of depression (34.6%), anxiety disorder (32.3%), and fear of COVID-19 infection (18.8%), which was significantly higher than that noted in close relatives. However, BRS coping score was not significantly different between the two groups. Overall, about one-third of the participants who developed COVID-19 infection had depression and one-third had anxiety disorders. One-fifth of the participants reported high fear, post-traumatic symptoms, and obsessive-compulsive symptoms, whereas one-sixth reported other neuropsychiatric manifestations.

Conclusion:

Patients who suffered from COVID-19 have a higher prevalence of depression, anxiety, and fear as compared to those to witnessed COVID-19 in relatives.
Palabras clave

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Indian J Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: India

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Tipo de estudio: Observational_studies / Risk_factors_studies Idioma: En Revista: Indian J Psychiatry Año: 2022 Tipo del documento: Article País de afiliación: India